Accelerating BCG Efficacy: Targeting Dendritic Cell Migration in Tuberculosis Immunization скачать в хорошем качестве

Accelerating BCG Efficacy: Targeting Dendritic Cell Migration in Tuberculosis Immunization

To celebrate International Women's Day 2026, we are highlighting Luciana's excellent talk from our Annual Meeting 2026. Speaking at the VALIDATE Annual Meeting 2026, Luciana explores a novel strategy to enhance the effectiveness of the BCG vaccine by improving how quickly the immune system is activated following vaccination. While BCG remains the only widely used vaccine against tuberculosis, its protective efficacy varies significantly in adolescents and adults, and one largely overlooked factor is the speed at which immune responses are initiated. Focusing on the role of dendritic cells in transporting antigens to lymph nodes, Luciana examines how metabolic regulation through the HIF1A pathway may enhance their migration and accelerate immune priming. This collaborative project between institutions in Argentina and the United States aims to generate new insights into early immune activation and identify potential markers of vaccine-induced protection, helping to inform future strategies for improving TB vaccines.